Incidence of Positive Endometrial Pipelle Biopsies for Endom | 88694

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Incidence of Positive Endometrial Pipelle Biopsies for Endometrial Carcinoma Diagnosis in Patients with Abnormal Uterine Bleeding

Author(s): Shumaila Javaid, Jabeen Atta, Bushra, Azra, Ome Kulsoom* and Meena Bai


Aim: The purpose of the study was to know the pervasiveness of positive endometrial biopsies in pre- and postmenopausal patients with abnormal uterine bleeding for the detection of endometrial cancer. Study design: A Cross-sectional study. Place and Duration: In the Obstetrics and Gynaecology Department of Sharif Postgraduate medical institute, Sharif medical city hospital Lahore Pakistan from May 2020 to May 2021. Methods: Pre- and postmenopausal women 35-70 years of age with abnormal uterine bleeding who met the inclusion and exclusion criteria were selected. A detailed interview and examination were obtained, informed consent, endometrial pipelle biopsy was performed. Each patient's biopsy was marked and sent to the Histopathology department for histopathological examination. A biopsy was considered positive if endometrial carcinoma was detected by histopathological examination and vice versa. Data were analyzed using SPSS version 20.0. For data analysis; Descriptive statistics were used. Results: Most of the patients (36.2%) belonged to the 35-45 age groups. The analysis of the distribution of births showed that the majority of women were multiparous (52.48%). Only 6.4% of cases were nulliparous. Most of the patients (58.2%) were postmenopausal. The most common symptom was menorrhagia, meaning that in 69.04% of cases; more than 80 ml of blood was lost per cycle in most cases. The most common histopathological finding in the Pipelle endometrium sample was the secretory endometrium, i.e. in 38.88% of cases. Conclusion: Pipelle biopsy is certainly a cost effective and beneficial method for identification of Endometrial carcinoma. By this, we can decrease the frequency of D&Cs performed in the operating room. The Pipelle accuracy is greater in postmenopausal women than in premenopausal females.

Share this article